Stocks · News reference
Nuwellis Announces Co-Promotion And Distribution Agreement With Atrility Medical For AtriAmp, Starting With Six-Month Program In Three Territories; Terms Not Disclosed
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Nuwellis shares are trading higher after the company announced continued commercial momentum for its Aquadex SmartFlow system, with 31 consoles sold year-to-date in 2026.
Nuwellis Says 31 Aquadex SmartFlow Consoles Sold Year-To-Date In 2026, Exceeding Full-Year Totals In Seven Of Past 10 Years; Reiterates 26% U.S. Revenue Growth In First Half
Nuwellis Says Financial Efficiency Strategy Drove Q2 2026 Gross Margin To 76% From 56%; Says It Had About $8.8M In Cash As Of August 31, With Runway Into Q3 2027